Genetic and epigenetic control of the regulatory machinery for skeletal development and bone formation: Contributions of vitamin D3

Vitamin D

Volumn , Issue , 2011, Pages 301-319

  Lian, Jane B ^a   Stein, Gary S ^a   Montecino, Martin ^b   Stein, Janet L ^a   Van Wijnen, Andre J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873995776     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10016-2     Document Type: Chapter

References (142)

1. Butterfield N.C., McGlinn E., Wicking C. The molecular regulation of vertebrate limb patterning. Curr. Top. Dev. Biol. 2010, 90:319-341.
2. Tarchini B., Duboule D. Control of Hoxd genes' collinearity during early limb development. Dev. Cell 2006, 10:93-103.
3. Dequeant M.L., Pourquie O. Segmental patterning of the vertebrate embryonic axis. Nat. Rev. Genet. 2008, 9:370-382.
4. Maronde E., Schilling A.F., Seitz S., Schinke T., Schmutz I., van der Horst G., et al. The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation. PLoS ONE 5:e.11527 2010.
5. Oka K., Oka S., Hosokawa R., Bringas P., Brockhoff H.C., Nonaka K., et al. TGF-beta mediated Dlx5 signaling plays a crucial role in osteo-chondroprogenitor cell lineage determination during mandible development. Dev. Biol. 2008, 321:303-309.
6. Li Z., Hassan M.Q., Volinia S., van Wijnen A.J., Stein J.L., Croce C.M., et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. USA 2008, 105:13906-13911.
7. Gaur T., Hussain S., Mudhasani R., Parulkar I., Colby J.L., Frederick D., et al. Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse. Dev. Biol. 2010, 340:10-21.
8. Hornstein E., Mansfield J.H., Yekta S., Hu J.K., Harfe B.D., McManus M.T., et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005, 438:671-674.
9. Minina E., Kreschel C., Naski M.C., Ornitz D.M., Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell 2002, 3:439-449.
10. Schipani E., Provot S. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. Birth Defects Res. C. Embryo. Today 2003, 69:352-362.
11. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A., Pirro A., et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996, 273:663-666.
12. Long F., Chung U.I., Ohba S., McMahon J., Kronenberg H.M., McMahon A.P. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004, 131:1309-1318.
13. Kobayashi T., Soegiarto D.W., Yang Y., Lanske B., Schipani E., McMahon A.P., et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J. Clin. Invest. 2005, 115:1734-1742.
14. Wan C., Shao J., Gilbert S.R., Riddle R.C., Long F., Johnson R.S., et al. Role of HIF-1alpha in skeletal development. Ann. N.Y. Acad. Sci. 2010, 1192:322-326.
15. Naja R.P., Dardenne O., Arabian A., St Arnaud R. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 2009, 150:4024-4032.
16. Lin R., Amizuka N., Sasaki T., Aarts M.M., Ozawa H., Goltzman D., et al. 1Alpha,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J. Bone Miner. Res. 2002, 17:1604-1612.
17. Pratap J., Lian J.B., Stein G.S. Metastatic bone disease: role of transcription factors and future targets. Bone. [Epub. ahead of print] 2010.
18. Usui M., Xing L., Drissi H., Zuscik M., O'Keefe R., Chen D., et al. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J. Bone Miner. Res. 2008, 23:314-325.
19. Joeng K.S., Long F. The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 2009, 136:4177-4185.
20. Mau E., Whetstone H., Yu C., Hopyan S., Wunder J.S., Alman B.A. PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms. Dev. Biol. 2007, 305:28-39.
21. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
22. Lefebvre V., Bhattaram P. Vertebrate skeletogenesis. Curr. Top. Dev. Biol. 2010, 90:291-317.
23. Yoshida C.A., Komori T. Role of Runx proteins in chondrogenesis. Crit. Rev. Eukaryot. Gene. Expr. 2005, 15:243-254.
24. Zaidi S.K., Young D.W., Montecino M., Lian J.B., van Wijnen A.J., Stein J.L., et al. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat. Rev. Genet. 2010, 11:583-589.
25. Lengner C.J., Hassan M.Q., Serra R.W., Lepper C., van Wijnen A.J., Stein J.L., et al. Nkx3.2 mediated repression of RUNX2 promotes chondrogenic differentiation. J. Biol. Chem. 2005, 280:15872-15879.
26. Provot S., Kempf H., Murtaugh L.C., Chung U.I., Kim D.W., Chyung J., et al. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 2006, 133:651-662.
27. Zhou G., Zheng Q., Engin F., Munivez E., Chen Y., Sebald E., et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. USA 2006, 103:19004-19009.
28. Napierala D., Sam K., Morello R., Zheng Q., Munivez E., Shivdasani R.A., et al. Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. Hum. Mol. Genet. 2008, 17:2244-2254.
29. Degnin C.R., Laederich M.B., Horton W.A. FGFs in endochondral skeletal development. J. Cell Biochem. 2010, 110:1046-1057.
30. Yu K., Ornitz D.M. FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development 2008, 135:483-491.
31. Amizuka N., Davidson D., Liu H., Valverde-Franco G., Chai S., Maeda T., et al. Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development. Bone 2004, 34:13-25.
32. Laederich M.B., Horton W.A. Achondroplasia: pathogenesis and implications for future treatment. Curr. Opin. Pediatr. 2010, 22:516-523.
33. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921.
34. Valverde-Franco G., Liu H., Davidson D., Chai S., Valderrama-Carvajal H., Goltzman D., et al. Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum. Mol. Genet. 2004, 13:271-284.
35. Ahn K., Mishina Y., Hanks M.C., Behringer R.R., Crenshaw E.B. BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 2001, 128:4449-4461.
36. Rosen V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 2009, 20:475-480.
37. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7:51-65.
38. Zaidi S.K., Sullivan A.J., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl. Acad. Sci. USA 2002, 99:8048-8053.
39. Javed A., Bae J.S., Afzal F., Gutierrez S., Pratap J., Zaidi S.K., et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J. Biol. Chem. 2008, 283:8412-8422.
40. Yang S., Wei D., Wang D., Phimphilai M., Krebsbach P.H., Franceschi R.T. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J. Bone Miner. Res. 2003, 18:705-715.
41. Balint E., Lapointe D., Drissi H., van der Meijden C., Young D.W., van Wijnen A.J., et al. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell Biochem. 2003, 89:401-426.
42. Chimal-Monroy J., Rodriguez-Leon J., Montero J.A., Ganan Y., Macias D., Merino R., et al. Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling. Dev. Biol. 2003, 257:292-301.
43. Blitz I.L., Cho K.W. Finding partners: how BMPs select their targets. Dev. Dyn. 2009, 238:1321-1331.
44. Moon R.T., Brown J.D., Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 1997, 13:157-162.
45. Glass D.A., Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology 2007, 148:2630-2634.
46. Yang Y. Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis. Birth Defects Res. Part C Embryo Today 2003, 69:305-317.
47. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. USA 2005, 102:3324-3329.
48. Williams B.O., Insogna K.L. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J. Bone Miner. Res. 2009, 24:171-178.
49. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
50. Schulze J., Seitz S., Saito H., Schneebauer M., Marshall R.P., Baranowsky A., et al. Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2. PLoS ONE 5:e.10309 2010.
51. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116:2627-2634.
52. Bodine P.V., Komm B.S. Wnt signaling and osteoblastogenesis. Rev. Endocr. Metab. Disord. 2006, 7:33-39.
53. ten Dijke P., Krause C., de Gorter D.J., Lowik C.W., Van Bezooijen R.L. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J. Bone Joint Surg. Am. 2008, 90(Suppl. 1):31-35.
54. Hartmann C. Skeletal development - Wnts are in control. Mol. Cells 2007, 24:177-184.
55. Itasaki N., Hoppler S. Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev. Dyn. 2010, 239:16-33.
56. ten Berge D., Brugmann S.A., Helms J.A., Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development 2008, 135:3247-3257.
57. Kim K.A., Wagle M., Tran K., Zhan X., Dixon M.A., Liu S., et al. R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol. Biol. Cell 2008, 19:2588-2596.
58. Wang F.S., Ko J.Y., Yeh D.W., Ke H.C., Wu H.L. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology 2008, 149:1793-1801.
59. Smith E., Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J. Biol. Chem. 2005, 280:2388-2394.
60. Fretz J.A., Zella L.A., Kim S., Shevde N.K., Pike J.W. 1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site. J. Steroid Biochem. Mol. Biol. 2007, 103:440-445.
61. Cianferotti L., Demay M.B. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J. Cell Biochem. 2007, 101:80-88.
62. Kramer I., Keller H., Leupin O., Kneissel M. Does osteocytic SOST suppression mediate PTH bone anabolism?. Trends Endocrinol. Metab. 2010, 21:237-244.
63. Wagner E.R., Zhu G., Zhang B.Q., Luo Q., Shi Q., Huang E., et al. The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr. Mol. Pharmacol. [Epub ahead of print]. 2010.
64. Stein G.S., Lian J.B., Stein J.L., van Wijnen A.J., Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 1996, 76:593-629.
65. Ali S.A., Zaidi S.K., Dacwag C.S., Salma N., Young D.W., Shakoori A.R., et al. Phenotypic transcription factors epigenetically mediate cell growth control. Proc. Natl. Acad. Sci. USA 2008, 105:6632-6637.
66. Kawai M., Rosen C.J. PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis. Nat. Rev. Endocrinol. [Epub ahead of print]. 2010.
67. Jensen E.D., Nair A.K., Westendorf J.J. Histone deacetylase co-repressor complex control of Runx2 and bone formation. Crit. Rev. Eukaryot. Gene. Expr. 2007, 17:187-196.
68. Noda M., Nifuji A., Tuji K., Furuya K., Ichiro S., Asou Y., et al. Transcription factors and osteoblasts. Front. Biosci. 1998, 3:d817-d820.
69. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 2004, 6:423-435.
70. de Frutos C.A., Dacquin R., Vega S., Jurdic P., Machuca-Gayet I., Nieto M.A. Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J. 2009, 28:686-696.
71. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
72. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
73. Rached M.T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 2010, 120:357-368.
74. Rached M.T., Kode A., Xu L., Yoshikawa Y., Paik J.H., DePinho R.A., et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010, 11:147-160.
75. Teixeira C.C., Liu Y., Thant L.M., Pang J.T., Palmer G., Alikhani M. FOXO1, a novel regulator of osteoblast differentiation and skeletogenesis. J. Biol. Chem. 2010, 285:31055-31065.
76. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., et al. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell Biol. 2004, 24:9248-9261.
77. Hassan M.Q., Saini S., Gordon J.A., van Wijnen A.J., Montecino M., Stein J.L., et al. Molecular switches involving homeodomain proteins, HOXA10 and RUNX2 regulate osteoblastogenesis. Cells Tissues Organs 2009, 189:122-125.
78. Hess J., Porte D., Munz C., Angel P. AP-1 and Cbfa/Runt physically interact and regulate PTH-dependent MMP13 expression in osteoblasts through a new OSE2/AP-1 composite element. J. Biol. Chem. 2001, 276:20029-20038.
79. Baniwal S.K., Khalid O., Sir D., Buchanan G., Coetzee G.A., Frenkel B. Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA. Mol. Endocrinol. 2009, 23:1203-1214.
80. Lian J.B., Javed A., Zaidi S.K., Lengner C., Montecino M., van Wijnen A.J., et al. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukaryot. Gene. Expr. 2004, 14:1-41.
81. Soltanoff C.S., Yang S., Chen W., Li Y.P. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit. Rev. Eukaryot. Gene. Expr. 2009, 19:1-46.
82. Zaidi S.K., Medina R.F., Pockwinse S.M., Bakshi R., Kota K.P., Ali S.A., et al. Subnuclear localization and intranuclear trafficking of transcription factors. Methods Mol. Biol. 2010, 647:77-93.
83. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
84. Stein G.S., Zaidi S.K., Stein J.L., Lian J.B., van Wijnen A.J., Montecino M., et al. Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: implications for biological control in cancer. Ann. N.Y. Acad. Sci. 2009, 1155:4-14.
85. Young D.W., Hassan M.Q., Pratap J., Galindo M., Zaidi S.K., Lee S.H., et al. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 2007, 445:442-446.
86. Young D.W., Hassan M.Q., Yang X.-Q., Galindo M., Javed A., Zaidi S.K., et al. Mitotic retention of gene expression patterns by the cell fate determining transcription factor Runx2. Proc. Natl. Acad. Sci. USA 2007, 104:3189-3194.
87. Ali S.A., Zaidi S.K., Dobson J.R., Shakoori A.R., Lian J.B., Stein J.L., et al. Transcriptional corepressor TLE1 functions with Runx2 in epigenetic repression of ribosomal RNA genes. Proc. Natl. Acad. Sci. USA 2010, 107:4165-4169.
88. Stein G.S., Lian J.B., Montecino M., et al. Skeletal gene expression in nuclear microenvironments. Principles of Bone Biology 2008, 263-283. Academic Press, San Diego, CA. Third ed. J.P. Bilezikian, L.G. Raisz, T.J. Martin (Eds.).
89. Montecino M., Stein G.S., Stein J.L., Lian J.B., van Wijnen A.J., Carvallo L., et al. Vitamin D control of gene expression: temporal and spatial parameters for organization of the regulatory machinery. Crit. Rev. Eukaryot. Gene Expr. 2008, 18:163-172.
90. Cosgrove M.S. Histone proteomics and the epigenetic regulation of nucleosome mobility. Expert Rev. Proteomics 2007, 4:465-478.
91. Guil S., Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 2009, 41:87-95.
92. Hudson D.F., Marshall K.M., Earnshaw W.C. Condensin: architect of mitotic chromosomes. Chromosome Res. 2009, 17:131-144.
93. Hall L.L., Byron M., Pageau G., Lawrence J.B. AURKB-mediated effects on chromatin regulate binding versus release of XIST RNA to the inactive chromosome. J. Cell Biol. 2009, 186:491-507.
94. Pande S., Ali S.A., Dowdy C., Zaidi S.K., Ito K., Ito Y., et al. Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes. J. Cell Physiol. 2009, 218:473-479.
95. Bakshi R., Zaidi S.K., Pande S., Hassan M.Q., Young D.W., Montecino M., et al. The leukemogenic t(8;21) fusion protein AML1-ETO controls ribosomal RNA genes and associates with nucleaolar organizing regions at mitotic chromosomes. J. Cell Sci. 2008, 21:3981-3990.
96. Cairns B.R. The logic of chromatin architecture and remodelling at promoters. Nature 2009, 461:193-198.
97. Ho L., Crabtree G.R. Chromatin remodelling during development. Nature 2010, 463:474-484.
98. Zaidi S.K., Young D.W., Montecino M., Lian J.B., Stein J.L., van Wijnen A.J., et al. Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory information. Mol. Cell Biol. 2010, 30:4758-4766.
99. Grande M.A., van der Kraan I., van Steensel B., Schul W., de The H., van der Voort H.T., et al. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell Biochem. 1996, 63:280-291.
100. Zeng C., McNeil S., Pockwinse S., Nickerson J.A., Shopland L., Lawrence J.B., et al. Intranuclear targeting of AML/CBFα regulatory factors to nuclear matrix-associated transcriptional domains. Proc. Natl. Acad. Sci. USA 1998, 95:1585-1589.
101. Harrington K.S., Javed A., Drissi H., McNeil S., Lian J.B., Stein J.L., et al. Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. J. Cell Sci. 2002, 115:4167-4176.
102. Ma H., Siegel A.J., Berezney R. Association of chromosome territories with the nuclear matrix. Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins. J. Cell Biol. 1999, 146:531-542.
103. Cook P.R. The organization of replication and transcription. Science 1999, 284:1790-1795.
104. van Steensel B., Jenster G., Damm K., Brinkmann A.O., van Driel R. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J. Cell Biochem. 1995, 57:465-478.
105. Htun H., Barsony J., Renyi I., Gould D.L., Hager G.L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 1996, 93:4845-4850.
106. Misteli T., Spector D.L. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol. Cell 1999, 3:697-705.
107. Choi J.-Y., Pratap J., Javed A., Zaidi S.K., Xing L., Balint E., et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci USA 2001, 98:8650-8655.
108. Vradii D., Zaidi S.K., Lian J.B., van Wijnen A.J., Stein J.L., Stein G.S. Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype. Proc. Natl. Acad. Sci USA 2005, 102:7174-7179.
109. Zaidi S.K., Dowdy C.R., van Wijnen A.J., Lian J.B., Raza A., Stein J.L., et al. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res. 2009, 69:8249-8255.
110. Javed A., Guo B., Hiebert S., Choi J.-Y., Green J., Zhao S.-C., et al. Groucho/TLE/R-Esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription. J. Cell Sci. 2000, 113:2221-2231.
111. Zeng C., van Wijnen A.J., Stein J.L., Meyers S., Sun W., Shopland L., et al. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBFα transcription factors. Proc. Natl. Acad. Sci. USA 1997, 94:6746-6751.
112. Zaidi S.K., Javed A., Pratap J., Schroeder T.M., Westendorf J., Lian J.B., et al. Alterations in intranuclear localization of Runx2 affect biological activity. J. Cell Physiol. 2006, 209:935-942.
113. Paredes R., Arriagada G., Cruzat F., Villagra A., Olate J., Zaidi K., et al. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol. Cell Biol. 2004, 24:8847-8861.
114. Arriagada G., Paredes R., van Wijnen A.J., Lian J.B., van Z.B., Stein G.S., et al. 1Alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1Alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA. J. Cell Physiol. 2010, 222:336-346.
115. Norman A.W., Mizwicki M.T., Norman D.P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 2004, 3:27-41.
116. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 2009, 10:295-304.
117. Albini S., Puri P.L. SWI/SNF complexes, chromatin remodeling and skeletal myogenesis: it's time to exchange!. Exp. Cell Res. 2010, 316:3073-3080.
118. de la Serna I., Imbalzano A.N. Unfolding heterochromatin for replication. Nat. Genet. 2002, 32:560-562.
119. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002, 108:475-487.
120. de la Serna I., Carlson K.A., Imbalzano A.N. Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat. Genet. 2001, 27:187-190.
121. Gutierrez J., Paredes R., Cruzat F., Hill D.A., van Wijnen A.J., Lian J.B., et al. Chromatin remodeling by SWI/SNF results in nucleosome mobilization to preferential positions in the rat osteocalcin gene promoter. J. Biol. Chem. 2007, 282:9445-9457.
122. Carrozza M.J., Utley R.T., Workman J.L., Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet. 2003, 19:321-329.
123. Fan H.Y., He X., Kingston R.E., Narlikar G.J. Distinct strategies to make nucleosomal DNA accessible. Mol. Cell 2003, 11:1311-1322.
124. Meyer M.B., Goetsch P.D., Pike J.W. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 2010, 121:136-141.
125. Cruzat F., Henriquez B., Villagra A., Hepp M., Lian J.B., van Wijnen A.J., et al. SWI/SNF-independent nuclease hypersensitivity and increased histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2. Biochemistry 2009, 48:7287-7295.
126. Bakshi R., Hassan M.Q., Pratap J., Lian J.B., Montecino M.A., van Wijnen A.J., et al. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J. Cell Physiol. 2010, 225:569-576.
127. Villagra A., Gutierrez J., Paredes R., Sierra J., Puchi M., Imschenetzky M., et al. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J. Cell Biochem. 2002, 85:112-122.
128. Shen J., Montecino M.A., Lian J.B., Stein G.S., van Wijnen A.J., Stein J.L. Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D dependent, bone tissue-specific transcription. J. Biol. Chem. 2002, 277:20284-20292.
129. Shen J., Hovhannisyan H., Lian J.B., Montecino M.A., Stein G.S., Stein J.L., et al. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol. Endocrinol. 2003, 17:743-756.
130. Arriagada G., Henriquez B., Moena D., Merino P., Ruiz-Tagle C., Lian J.B., et al. Recruitment and subnuclear distribution of the regulatory machinery during 1alpha,25-dihydroxy vitamin D3-mediated transcriptional upregulation in osteoblasts. J. Steroid. Biochem. Mol. Biol. 2010, 121:156-158.
131. Gutierrez S., Liu J., Javed A., Montecino M., Stein G.S., Lian J.B., et al. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J. Biol. Chem. 2004, 279:43581-43588.
132. Paredes R., Arriagada G., Cruzat F., Olate J., van Wijnen A., Lian J., et al. The Runx2 transcription factor plays a key role in the 1α,25-dihydroxy vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J. Steroid. Biochem. Mol. Biol. 2004, 89-90:269-271.
133. Javed A., Gutierrez S., Montecino M., van Wijnen A.J., Stein J.L., Stein G.S., et al. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D responsive transcription and contribute to chromatin organization. Mol. Cell Biol. 1999, 19:7491-7500.
134. Gutierrez J., Sierra J., Medina R., Puchi M., Imschenetzky M., Hiebert S., et al. Interaction of CBFα/AML/PEBP2α transcription factors with nucleosomal sequences requires flexibility in the translational positioning of the histone octamer and exposure of the Cbfα site. Biochemistry 2000, 39:13565-13574.
135. Marcellini S., Bruna C., Henriquez J.P., Albistur M., Reyes A.E., Barriga E.H., et al. Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis. BMC. Evol. Biol. 2010, 10:78.
136. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
137. Sierra J., Villagra A., Paredes R., Cruzat F., Gutierrez S., Arriagada G., et al. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyl transferase activity. Mol. Cell Biol. 2003, 23:3339-3351.
138. Spencer V.A., Davie J.R. Role of covalent modifications of histones in regulating gene expression. Gene 1999, 240:1-12.
139. Kitabayashi I., Yokoyama A., Shimizu K., Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 1998, 17:2994-3004.
140. Mink S., Haenig B., Klempnauer K.H. Interaction and functional collaboration of p300 and C/EBPbeta. Mol. Cell Biol. 1997, 17:6609-6617.
141. Gutierrez S., Javed A., Tennant D., van Rees M., Montecino M., Stein G.S., et al. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 2002, 277:1316-1323.
142. Kowenz-Leutz E., Leutz A. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 1999, 4:735-743.